Cargando…

Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor

Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) belong to a superfamily of nuclear receptors called steroid hormone receptors, which, upon binding ligand, dimerize and translocate to the nucleus where they activate or repress the transcription of a large number of genes, thus modulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mal, Rahul, Magner, Alexa, David, Joel, Datta, Jharna, Vallabhaneni, Meghna, Kassem, Mahmoud, Manouchehri, Jasmine, Willingham, Natalie, Stover, Daniel, Vandeusen, Jeffery, Sardesai, Sagar, Williams, Nicole, Wesolowski, Robert, Lustberg, Maryam, Ganju, Ramesh K., Ramaswamy, Bhuvaneswari, Cherian, Mathew A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645238/ https://www.ncbi.nlm.nih.gov/pubmed/33194742 http://dx.doi.org/10.3389/fonc.2020.587386

Ejemplares similares

Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
por: Manouchehri, Jasmine M., et al.
Publicado: (2022)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020)

LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY
por: Williams, Nicole, et al.
Publicado: (2019)

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study
por: Morgan, Evan, et al.
Publicado: (2020)

TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature
por: Boutrid, Hinda, et al.
Publicado: (2020)

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
por: Wesolowski, Robert, et al.
Publicado: (2020)

A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study
por: Zvinovski, Filadelfiya, et al.
Publicado: (2021)

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Tumor lysis Syndrome in a Patient with Metastatic Breast Cancer Treated with Alpelisib
por: Handy, Caitlin, et al.
Publicado: (2021)

Metastatic breast cancer patient perceptions of somatic tumor genomic testing
por: Adams, Elizabeth J., et al.
Publicado: (2020)

Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls
por: Johnson, Kai CC, et al.
Publicado: (2023)

Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
por: Grimm, Michael, et al.
Publicado: (2022)

Long-Term Follow-Up of Fractional CO(2) Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors
por: Quick, Allison M., et al.
Publicado: (2022)

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Johnson, Kai Conrad Cecil, et al.
Publicado: (2023)

Genomic features of rapid versus late relapse in triple negative breast cancer
por: Zhang, Yiqing, et al.
Publicado: (2021)

Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors
por: Sukumar, Jasmine S., et al.
Publicado: (2022)

Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
por: Benner, Brooke, et al.
Publicado: (2020)

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature
por: Patel, Sandipkumar H, et al.
Publicado: (2021)

The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
por: Bhateja, Priyanka, et al.
Publicado: (2019)

Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses’ health study
por: Asad, Sarah, et al.
Publicado: (2022)

Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
por: Mishra, Sanjay, et al.
Publicado: (2021)

Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy
por: Garcia-Villa, Alejandra, et al.
Publicado: (2012)

Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship
por: Madison, Annelise A., et al.
Publicado: (2023)

Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
por: Charan, Manish, et al.
Publicado: (2020)

microRNA-107 functions as a candidate tumor suppressor gene in head and neck squamous cell carcinoma by down-regulation of protein kinase Cε
por: Datta, Jharna, et al.
Publicado: (2011)

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
por: Lustberg, Maryam B, et al.
Publicado: (2014)

Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer
por: Basree, Mustafa M., et al.
Publicado: (2019)

Advances in Bio-Optical Imaging for the Diagnosis of Early Oral Cancer
por: Olivo, Malini, et al.
Publicado: (2011)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
por: Pant, Shubham, et al.
Publicado: (2008)

HOXB13, a Target of DNMT3B, Is Methylated at an Upstream CpG Island, and Functions as a Tumor Suppressor in Primary Colorectal Tumors
por: Ghoshal, Kalpana, et al.
Publicado: (2010)

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study
por: Wesolowski, Robert, et al.
Publicado: (2020)

Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin
por: Pahouja, Gaurav, et al.
Publicado: (2014)

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
por: Bhuvaneswari, Ramaswamy, et al.
Publicado: (2009)

TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment
por: Manouchehri, Jasmine M, et al.
Publicado: (2018)

Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin
por: Turner, Katherine A., et al.
Publicado: (2018)

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer Control
por: Sudhakaran, Meenakshi, et al.
Publicado: (2019)

Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series
por: Blow, Tahj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3k7hc7ki5hh323k86hvp0i945